189 related articles for article (PubMed ID: 455228)
21. [Clinical study on prognostic factors in thyroid carcinoma].
Tachikawa T; Kumazawa H; Kyomoto R; Yukawa H; Yamashita T; Nishikawa M
Nihon Jibiinkoka Gakkai Kaiho; 2001 Feb; 104(2):157-64. PubMed ID: 11257780
[TBL] [Abstract][Full Text] [Related]
22. [Prognostically relevant factors in follicular thyroid cancer].
Böttger T; Klupp J; Sorger K; Junginger T
Langenbecks Arch Chir; 1990; 375(5):266-71. PubMed ID: 2259260
[TBL] [Abstract][Full Text] [Related]
23. Some factors influencing the survival of patients with less advanced stages of differentiated thyroid cancer.
Nĕmec J; Zamrazil V; Pohunkovå D; Röhling S; Zeman V
Endocrinol Exp; 1986 Mar; 20(1):85-95. PubMed ID: 3486115
[TBL] [Abstract][Full Text] [Related]
24. [Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].
Witte J; Schlotmann U; Simon D; Dotzenrath C; Ohmann C; Goretzki PE
Zentralbl Chir; 1997; 122(4):259-65. PubMed ID: 9221636
[TBL] [Abstract][Full Text] [Related]
25. [Differentiated cancers].
Görtz G; Häring R
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():961-6. PubMed ID: 1983687
[TBL] [Abstract][Full Text] [Related]
26. Thyroid cancer. Survival in 148 cases followed for 10 years or more.
Torres J; Volpato RD; Power EG; Lopez EC; Dominguez ME; Maira JL; Ugarte JA; Martinez VC
Cancer; 1985 Nov; 56(9):2298-304. PubMed ID: 4052973
[TBL] [Abstract][Full Text] [Related]
27. Prognostic importance of various clinicopathological features in papillary thyroid carcinoma.
Akslen LA; Myking AO; Salvesen H; Varhaug JE
Eur J Cancer; 1992; 29A(1):44-51. PubMed ID: 1445745
[TBL] [Abstract][Full Text] [Related]
28. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
29. Thyroid carcinoma: a follow-up study of 11 years.
Ritzl F; Siebers G; Neumann C; Ritzl EK
Radiat Environ Biophys; 1987; 26(4):283-8. PubMed ID: 3685251
[TBL] [Abstract][Full Text] [Related]
30. Surgical therapy for thyroid carcinoma: a review of 1249 solitary thyroid nodules.
Brooks JR; Starnes HF; Brooks DC; Pelkey JN
Surgery; 1988 Dec; 104(6):940-6. PubMed ID: 3194845
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases.
Ghossein R; Ganly I; Biagini A; Robenshtok E; Rivera M; Tuttle RM
Thyroid; 2014 Feb; 24(2):245-53. PubMed ID: 23745671
[TBL] [Abstract][Full Text] [Related]
32. The Flip Side of NIFTP: an Increase in Rates of Unfavorable Histologic Parameters in the Remainder of Papillary Thyroid Carcinomas.
Wong KS; Strickland KC; Angell TE; Nehs MA; Alexander EK; Cibas ES; Krane JF; Howitt BE; Barletta JA
Endocr Pathol; 2017 Jun; 28(2):171-176. PubMed ID: 28271380
[TBL] [Abstract][Full Text] [Related]
33. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
34. Canadian survey of thyroid cancer.
Simpson WJ; McKinney SE
Can Med Assoc J; 1985 Apr; 132(8):925-31. PubMed ID: 3978516
[TBL] [Abstract][Full Text] [Related]
35. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
Chang HY; Lin JD; Chou SC; Chao TC; Hsueh C
Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702
[TBL] [Abstract][Full Text] [Related]
36. Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma.
Yamashita H; Noguchi S; Murakami N; Kawamoto H; Watanabe S
Cancer; 1997 Dec; 80(12):2268-72. PubMed ID: 9404704
[TBL] [Abstract][Full Text] [Related]
37. Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients.
Oyer SL; Fritsch VA; Lentsch EJ
Ann Otol Rhinol Laryngol; 2014 Feb; 123(2):94-100. PubMed ID: 24574464
[TBL] [Abstract][Full Text] [Related]
38. Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classic papillary thyroid carcinoma?
Song E; Jeon MJ; Oh HS; Han M; Lee YM; Kim TY; Chung KW; Kim WB; Shong YK; Song DE; Kim WG
Eur J Endocrinol; 2018 Sep; 179(3):135-142. PubMed ID: 29875289
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors of papillary, follicular and medullary carcinomas of the thyroid gland. Retrospective multivariate analysis of 216 patients with a median follow-up of 11 years.
Tennvall J; Biörklund A; Möller T; Ranstam J; Akerman M
Acta Radiol Oncol; 1985; 24(1):17-24. PubMed ID: 2984898
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in differentiated carcinoma of the thyroid gland.
Shah JP; Loree TR; Dharker D; Strong EW; Begg C; Vlamis V
Am J Surg; 1992 Dec; 164(6):658-61. PubMed ID: 1463119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
